• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MiCML:一个用于利用微生物组谱分析治疗效果的因果机器学习云平台。

MiCML: a causal machine learning cloud platform for the analysis of treatment effects using microbiome profiles.

作者信息

Koh Hyunwook, Kim Jihun, Jang Hyojung

机构信息

Department of Applied Mathematics and Statistics, The State University of New York, Korea, Incheon, South Korea.

出版信息

BioData Min. 2025 Jan 30;18(1):10. doi: 10.1186/s13040-025-00422-3.

DOI:10.1186/s13040-025-00422-3
PMID:39885552
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11783787/
Abstract

BACKGROUND

The treatment effects are heterogenous across patients due to the differences in their microbiomes, which in turn implies that we can enhance the treatment effect by manipulating the patient's microbiome profile. Then, the coadministration of microbiome-based dietary supplements/therapeutics along with the primary treatment has been the subject of intensive investigation. However, for this, we first need to comprehend which microbes help (or prevent) the treatment to cure the patient's disease.

RESULTS

In this paper, we introduce a cloud platform, named microbiome causal machine learning (MiCML), for the analysis of treatment effects using microbiome profiles on user-friendly web environments. MiCML is in particular unique with the up-to-date features of (i) batch effect correction to mitigate systematic variation in collective large-scale microbiome data due to the differences in their underlying batches, and (ii) causal machine learning to estimate treatment effects with consistency and then discern microbial taxa that enhance (or lower) the efficacy of the primary treatment. We also stress that MiCML can handle the data from either randomized controlled trials or observational studies.

CONCLUSION

We describe MiCML as a useful analytic tool for microbiome-based personalized medicine. MiCML is freely available on our web server ( http://micml.micloud.kr ). MiCML can also be implemented locally on the user's computer through our GitHub repository ( https://github.com/hk1785/micml ).

摘要

背景

由于患者微生物群存在差异,治疗效果在不同患者中具有异质性,这反过来意味着我们可以通过操纵患者的微生物群特征来提高治疗效果。因此,将基于微生物群的膳食补充剂/治疗方法与主要治疗联合使用一直是深入研究的课题。然而,要做到这一点,我们首先需要了解哪些微生物有助于(或预防)治疗以治愈患者的疾病。

结果

在本文中,我们介绍了一个名为微生物群因果机器学习(MiCML)的云平台,用于在用户友好的网络环境中使用微生物群特征分析治疗效果。MiCML尤其独特之处在于具有以下最新功能:(i)批次效应校正,以减轻由于底层批次差异导致的大规模微生物群数据中的系统变异;(ii)因果机器学习,以一致地估计治疗效果,然后识别增强(或降低)主要治疗效果的微生物分类群。我们还强调,MiCML可以处理来自随机对照试验或观察性研究的数据。

结论

我们将MiCML描述为基于微生物群的个性化医学的有用分析工具。MiCML可在我们的网络服务器(http://micml.micloud.kr)上免费获取。MiCML也可以通过我们的GitHub仓库(https://github.com/hk1785/micml)在用户计算机上本地实现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a924/11783787/e389c927e330/13040_2025_422_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a924/11783787/fdefbe85ab40/13040_2025_422_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a924/11783787/41f126f79f45/13040_2025_422_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a924/11783787/780c3cd74105/13040_2025_422_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a924/11783787/48bf7dcce80a/13040_2025_422_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a924/11783787/ea28214e2100/13040_2025_422_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a924/11783787/56f62795bc2e/13040_2025_422_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a924/11783787/29634ea9619a/13040_2025_422_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a924/11783787/e389c927e330/13040_2025_422_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a924/11783787/fdefbe85ab40/13040_2025_422_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a924/11783787/41f126f79f45/13040_2025_422_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a924/11783787/780c3cd74105/13040_2025_422_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a924/11783787/48bf7dcce80a/13040_2025_422_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a924/11783787/ea28214e2100/13040_2025_422_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a924/11783787/56f62795bc2e/13040_2025_422_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a924/11783787/29634ea9619a/13040_2025_422_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a924/11783787/e389c927e330/13040_2025_422_Fig8_HTML.jpg

相似文献

1
MiCML: a causal machine learning cloud platform for the analysis of treatment effects using microbiome profiles.MiCML:一个用于利用微生物组谱分析治疗效果的因果机器学习云平台。
BioData Min. 2025 Jan 30;18(1):10. doi: 10.1186/s13040-025-00422-3.
2
MiSurv: an Integrative Web Cloud Platform for User-Friendly Microbiome Data Analysis with Survival Responses.MiSurv:一个集成的 Web 云平台,用于用户友好的微生物组数据分析和生存响应。
Microbiol Spectr. 2023 Jun 15;11(3):e0505922. doi: 10.1128/spectrum.05059-22. Epub 2023 Apr 11.
3
MiCloud: A unified web platform for comprehensive microbiome data analysis.MiCloud:一个用于综合微生物组数据分析的统一网络平台。
PLoS One. 2022 Aug 1;17(8):e0272354. doi: 10.1371/journal.pone.0272354. eCollection 2022.
4
A unified web cloud computing platform MiMedSurv for microbiome causal mediation analysis with survival responses.用于微生物组因果中介分析和生存反应的统一网络云计算平台 MiMedSurv。
Sci Rep. 2024 Sep 4;14(1):20650. doi: 10.1038/s41598-024-71852-y.
5
Integrative web cloud computing and analytics using MiPair for design-based comparative analysis with paired microbiome data.使用MiPair进行基于设计的配对微生物组数据比较分析的集成网络云计算与分析。
Sci Rep. 2022 Nov 28;12(1):20465. doi: 10.1038/s41598-022-25093-6.
6
Comprehensive microbiome causal mediation analysis using MiMed on user-friendly web interfaces.使用MiMed在用户友好的网页界面上进行综合微生物组因果中介分析。
Biol Methods Protoc. 2023 Oct 4;8(1):bpad023. doi: 10.1093/biomethods/bpad023. eCollection 2023.
7
MiTree: A Unified Web Cloud Analytic Platform for User-Friendly and Interpretable Microbiome Data Mining Using Tree-Based Methods.MiTree:一个统一的基于树状方法的网络云分析平台,用于实现用户友好且可解释的微生物组数据挖掘。
Microorganisms. 2023 Nov 20;11(11):2816. doi: 10.3390/microorganisms11112816.
8
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
9
Microbiome Search Engine 2: a Platform for Taxonomic and Functional Search of Global Microbiomes on the Whole-Microbiome Level.微生物组搜索引擎2:一个在全微生物组水平上对全球微生物组进行分类和功能搜索的平台。
mSystems. 2021 Jan 19;6(1):e00943-20. doi: 10.1128/mSystems.00943-20.
10
mAML: an automated machine learning pipeline with a microbiome repository for human disease classification.mAML:一个带有微生物组库的自动化机器学习管道,用于人类疾病分类。
Database (Oxford). 2020 Jan 1;2020. doi: 10.1093/database/baaa050.

本文引用的文献

1
MiTree: A Unified Web Cloud Analytic Platform for User-Friendly and Interpretable Microbiome Data Mining Using Tree-Based Methods.MiTree:一个统一的基于树状方法的网络云分析平台,用于实现用户友好且可解释的微生物组数据挖掘。
Microorganisms. 2023 Nov 20;11(11):2816. doi: 10.3390/microorganisms11112816.
2
Comprehensive microbiome causal mediation analysis using MiMed on user-friendly web interfaces.使用MiMed在用户友好的网页界面上进行综合微生物组因果中介分析。
Biol Methods Protoc. 2023 Oct 4;8(1):bpad023. doi: 10.1093/biomethods/bpad023. eCollection 2023.
3
Subgroup Identification Using Virtual Twins for Human Microbiome Studies.
利用虚拟双胞胎进行人类微生物组研究的亚组识别。
IEEE/ACM Trans Comput Biol Bioinform. 2023 Nov-Dec;20(6):3800-3808. doi: 10.1109/TCBB.2023.3324139. Epub 2023 Dec 25.
4
Integrative web cloud computing and analytics using MiPair for design-based comparative analysis with paired microbiome data.使用MiPair进行基于设计的配对微生物组数据比较分析的集成网络云计算与分析。
Sci Rep. 2022 Nov 28;12(1):20465. doi: 10.1038/s41598-022-25093-6.
5
Combined IgE neutralization and Bifidobacterium longum supplementation reduces the allergic response in models of food allergy.联合 IgE 中和和长双歧杆菌补充可减少食物过敏模型中的过敏反应。
Nat Commun. 2022 Sep 27;13(1):5669. doi: 10.1038/s41467-022-33176-1.
6
Batch effects removal for microbiome data via conditional quantile regression.通过条件分位数回归去除微生物组数据的批次效应。
Nat Commun. 2022 Sep 15;13(1):5418. doi: 10.1038/s41467-022-33071-9.
7
The combination of microbiome and metabolome to analyze the cross-cooperation mechanism of polysaccharide with the gut microbiota and .从宏基因组和代谢组学角度分析多糖与肠道微生物群互作的协同机制。
Food Funct. 2022 Oct 3;13(19):10069-10082. doi: 10.1039/d2fo02336a.
8
Gut microbiome in modulating immune checkpoint inhibitors.肠道微生物组在调节免疫检查点抑制剂中的作用。
EBioMedicine. 2022 Aug;82:104163. doi: 10.1016/j.ebiom.2022.104163. Epub 2022 Jul 15.
9
IgM-associated gut bacteria in obesity and type 2 diabetes in C57BL/6 mice and humans.肥胖和 2 型糖尿病患者与 IgM 相关的肠道细菌:C57BL/6 小鼠和人类的研究。
Diabetologia. 2022 Aug;65(8):1398-1411. doi: 10.1007/s00125-022-05711-8. Epub 2022 May 19.
10
Elucidating the role of the gut microbiota in the physiological effects of dietary fiber.阐明膳食纤维在生理效应中对肠道微生物群的作用。
Microbiome. 2022 May 13;10(1):77. doi: 10.1186/s40168-022-01248-5.